Mirati Therapeutics Inc 's

• MRTX's Stock Performance relative to its Competitors

Aptevo Therapeutics Inc Share Performance -45.77% 30 Days

Aptevo Therapeutics Inc Profile Aptevo Therapeutics Inc operates as a biotechnology company that focuses on the development of novel oncology and hematology therapeutics. The company primarily generates revenue through the sale of its products and potential collaborations with other pharmaceutical companies. More about Aptevo Therapeutics Inc 's Market Share

Bristol myers Squibb Company Share Performance -0.41% 30 Days

Bristol myers Squibb Company Profile Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes. More about Bristol myers Squibb Company's Market Share

Bolt Biotherapeutics Inc Share Performance +9.57% 30 Days

Bolt Biotherapeutics Inc Profile Bolt Biotherapeutics Inc's business model focuses on developing novel immunotherapies for the treatment of cancer. More about Bolt Biotherapeutics Inc 's Market Share

Blueprint Medicines Corporation Share Performance +48.51% This Year

Blueprint Medicines Corporation Profile The business model of Blueprint Medicines Corporation revolves around the development and commercialization of precision therapies for patients with genomically defined cancers and rare diseases. They actively pursue a strategy of genomically targeted drug discovery and development, utilizing advanced technologies and clinical expertise to bring potentially life-changing treatments to market. The company focuses on creating value through strategic collaborations, licensing agreements, and the commercialization of their innovative therapies. More about Blueprint Medicines Corporation's Market Share

Biophytis Sa Share Performance -56.72% This Quarter

Biophytis Sa Profile Biophytis SA is a biotechnology company that focuses on developing innovative therapeutics for age-related diseases, with a specific emphasis on degenerative eye diseases and muscle wasting conditions. They leverage their expertise in biology and clinical development to discover and advance targeted drug candidates, aiming to address the unmet medical needs of patients in these areas. More about Biophytis Sa's Market Share

Sources: Mirati Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 7:00 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Mirati Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.